/Companies

Nanostring

acquired by Bruker

4 known investors

Find your way into Nanostring

Sign up to see every warm intro you have to Nanostring

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Nanostring team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Acquired by Bruker Corporation April 2024 · $392.6M (approximately $392.6 million in cash for substantially all assets) · source ↗

NanoString (part of Bruker Spatial Biology) develops instruments and assays for spatial biology and gene expression analysis, including single-cell and subcellular spatial transcriptomics, proteomics, and multiomics. Its systems serve researchers in oncology, biomarker discovery, neuroscience, and translational and clinical research.

Investors · 4

Founder mafia

4 people who came through Nanostring went on to found or lead other companies.

Related companies · 2

Companies working in the same space as Nanostring.

Frequently asked questions

What does Nanostring do?
NanoString (part of Bruker Spatial Biology) develops instruments and assays for spatial biology and gene expression analysis, including single-cell and subcellular spatial transcriptomics, proteomics, and multiomics. Its systems serve researchers in oncology, biomarker discovery, neuroscience, and translational and clinical research.
Who are Nanostring's investors?
Nanostring's investors include Aspect Ventures, Foresite Capital, Kicker Ventures, Owl Capital.
Who acquired Nanostring?
Nanostring was acquired by Bruker.